• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022

    5/24/22 10:04:33 AM ET
    $AFL
    $ALL
    $CB
    $CRL
    Accident &Health Insurance
    Finance
    Property-Casualty Insurers
    Finance
    Get the next $AFL alert in real time by email

    Upgrades

    Susquehanna upgraded the previous rating for Lattice Semiconductor Corp (NASDAQ:LSCC) from Neutral to Positive. In the first quarter, Lattice Semiconductor showed an EPS of $0.37, compared to $0.22 from the year-ago quarter. The current stock performance of Lattice Semiconductor shows a 52-week-high of $85.45 and a 52-week-low of $43.59. Moreover, at the end of the last trading period, the closing price was at $48.82.

    According to Barclays, the prior rating for Otis Worldwide Corp (NYSE:OTIS) was changed from Equal-Weight to Overweight. In the first quarter, Otis Worldwide showed an EPS of $0.77, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $92.84 and a 52-week-low of $71.07. At the end of the last trading period, Otis Worldwide closed at $73.87.

    B of A Securities upgraded the previous rating for Northwest Natural Holding Co (NYSE:NWN) from Underperform to Neutral. Northwest Natural Hldg earned $1.80 in the first quarter, compared to $1.94 in the year-ago quarter. The stock has a 52-week-high of $57.63 and a 52-week-low of $43.07. At the end of the last trading period, Northwest Natural Hldg closed at $52.48.

    According to Morgan Stanley, the prior rating for Marqeta Inc (NASDAQ:MQ) was changed from Equal-Weight to Overweight. The stock has a 52-week-high of $37.90 and a 52-week-low of $6.05. At the end of the last trading period, Marqeta closed at $9.73.

    For Snowflake Inc (NYSE:SNOW), Rosenblatt upgraded the previous rating of Neutral to Buy. For the fourth quarter, Snowflake had an EPS of $0.12, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $405.00 and a 52-week-low of $126.01. At the end of the last trading period, Snowflake closed at $138.85.

    See all analyst ratings upgrades.

    Downgrades

    For CynergisTek Inc (AMEX:CTEK), Craig-Hallum downgraded the previous rating of Buy to Hold. For the first quarter, CynergisTek had an EPS of $0.07, compared to year-ago quarter EPS of $0.08. The current stock performance of CynergisTek shows a 52-week-high of $2.85 and a 52-week-low of $0.58. Moreover, at the end of the last trading period, the closing price was at $0.59.

    According to Stephens & Co., the prior rating for OncoCyte Corp (NASDAQ:OCX) was changed from Overweight to Equal-Weight. OncoCyte earned $0.11 in the first quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.25 and a 52-week-low of $1.07. OncoCyte closed at $1.08 at the end of the last trading period.

    According to B. Riley Securities, the prior rating for INmune Bio Inc (NASDAQ:INMB) was changed from Buy to Neutral. INmune Bio earned $0.39 in the first quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $30.37 and a 52-week-low of $6.18. At the end of the last trading period, INmune Bio closed at $7.27.

    According to Barclays, the prior rating for Eaton Corp PLC (NYSE:ETN) was changed from Equal-Weight to Underweight. Eaton Corp earned $1.62 in the first quarter, compared to $1.44 in the year-ago quarter. The stock has a 52-week-high of $175.72 and a 52-week-low of $132.16. At the end of the last trading period, Eaton Corp closed at $136.76.

    For Nautilus Inc (NYSE:NLS), Craig-Hallum downgraded the previous rating of Buy to Hold. Nautilus earned $0.58 in the fourth quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $18.58 and a 52-week-low of $2.34. At the end of the last trading period, Nautilus closed at $2.51.

    For Switch Inc (NYSE:SWCH), Berenberg downgraded the previous rating of Buy to Hold. Switch earned $0.04 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Switch shows a 52-week-high of $33.84 and a 52-week-low of $18.39. Moreover, at the end of the last trading period, the closing price was at $33.37.

    For Roblox Corp (NYSE:RBLX), Atlantic Equities downgraded the previous rating of Overweight to Neutral. For the first quarter, Roblox had an EPS of $0.27, compared to year-ago quarter EPS of $0.46. The current stock performance of Roblox shows a 52-week-high of $141.60 and a 52-week-low of $21.65. Moreover, at the end of the last trading period, the closing price was at $30.06.

    According to Keybanc, the prior rating for WalkMe Ltd (NASDAQ:WKME) was changed from Overweight to Sector Weight. WalkMe earned $0.22 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of WalkMe shows a 52-week-high of $34.42 and a 52-week-low of $11.40. Moreover, at the end of the last trading period, the closing price was at $12.20.

    See all analyst ratings downgrades.

    Initiations

    Citigroup initiated coverage on Unum Group (NYSE:UNM) with a Neutral rating. For the first quarter, Unum had an EPS of $1.36, compared to year-ago quarter EPS of $1.04. The stock has a 52-week-high of $36.73 and a 52-week-low of $22.25. At the end of the last trading period, Unum closed at $35.18.

    With a Buy rating, Lake Street initiated coverage on Winc Inc (AMEX:WBEV). The price target seems to have been set at $6.00 for Winc. The stock has a 52-week-high of $8.66 and a 52-week-low of $2.01. At the end of the last trading period, Winc closed at $2.17.

    Citigroup initiated coverage on Voya Financial Inc (NYSE:VOYA) with a Buy rating. The price target for Voya Financial is set to $82.00. For the first quarter, Voya Financial had an EPS of $1.47, compared to year-ago quarter EPS of $1.03. The stock has a 52-week-high of $74.97 and a 52-week-low of $58.97. At the end of the last trading period, Voya Financial closed at $64.93.

    DA Davidson initiated coverage on ITHAX Acquisition Corp (NASDAQ:ITHX) with a Buy rating. The price target for ITHAX Acquisition is set to $13.50. The stock has a 52-week-high of $10.30 and a 52-week-low of $9.60. At the end of the last trading period, ITHAX Acquisition closed at $9.80.

    With a Buy rating, CL King initiated coverage on The Hain Celestial Group Inc (NASDAQ:HAIN). The price target seems to have been set at $35.00 for Hain Celestial Group. For the third quarter, Hain Celestial Group had an EPS of $0.33, compared to year-ago quarter EPS of $0.44. The current stock performance of Hain Celestial Group shows a 52-week-high of $48.88 and a 52-week-low of $24.11. Moreover, at the end of the last trading period, the closing price was at $24.91.

    Guggenheim initiated coverage on HilleVax Inc (NASDAQ:HLVX) with a Buy rating. The price target for HilleVax is set to $40.00. The current stock performance of HilleVax shows a 52-week-high of $20.95 and a 52-week-low of $9.00. Moreover, at the end of the last trading period, the closing price was at $9.50.

    Cantor Fitzgerald initiated coverage on Lyra Therapeutics Inc (NASDAQ:LYRA) with an Overweight rating. The price target for Lyra Therapeutics is set to $15.00. Lyra Therapeutics earned $0.54 in the first quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Lyra Therapeutics shows a 52-week-high of $9.98 and a 52-week-low of $3.30. Moreover, at the end of the last trading period, the closing price was at $6.07.

    SVB Leerink initiated coverage on HilleVax Inc (NASDAQ:HLVX) with an Outperform rating. The price target for HilleVax is set to $30.00. At the moment, the stock has a 52-week-high of $20.95 and a 52-week-low of $9.00. HilleVax closed at $9.50 at the end of the last trading period.

    With a Neutral rating, Colliers Securities initiated coverage on INDUS Realty Trust Inc (NASDAQ:INDT). The price target seems to have been set at $70.00 for INDUS Realty Trust. For the first quarter, INDUS Realty Trust had an EPS of $0.38, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $82.94 and a 52-week-low of $61.36. INDUS Realty Trust closed at $63.19 at the end of the last trading period.

    With an Overweight rating, JP Morgan initiated coverage on HilleVax Inc (NASDAQ:HLVX). The price target seems to have been set at $24.00 for HilleVax. The current stock performance of HilleVax shows a 52-week-high of $20.95 and a 52-week-low of $9.00. Moreover, at the end of the last trading period, the closing price was at $9.50.

    Citigroup initiated coverage on The Travelers Companies Inc (NYSE:TRV) with a Neutral rating. The price target for Travelers Companies is set to $179.00. For the first quarter, Travelers Companies had an EPS of $4.22, compared to year-ago quarter EPS of $2.73. The stock has a 52-week-high of $187.98 and a 52-week-low of $144.44. At the end of the last trading period, Travelers Companies closed at $172.10.

    With a Sell rating, Citigroup initiated coverage on Reinsurance Group of America Inc (NYSE:RGA). The price target seems to have been set at $110.00 for Reinsurance Group. For the first quarter, Reinsurance Group had an EPS of $0.47, compared to year-ago quarter EPS of $1.24. The stock has a 52-week-high of $128.93 and a 52-week-low of $94.32. At the end of the last trading period, Reinsurance Group closed at $121.74.

    Citigroup initiated coverage on Prudential Financial Inc (NYSE:PRU) with a Neutral rating. The price target for Prudential Financial is set to $100.00. For the first quarter, Prudential Financial had an EPS of $3.17, compared to year-ago quarter EPS of $4.11. At the moment, the stock has a 52-week-high of $124.22 and a 52-week-low of $94.51. Prudential Financial closed at $101.40 at the end of the last trading period.

    With a Buy rating, Stifel initiated coverage on HilleVax Inc (NASDAQ:HLVX). The price target seems to have been set at $34.00 for HilleVax. At the moment, the stock has a 52-week-high of $20.95 and a 52-week-low of $9.00. HilleVax closed at $9.50 at the end of the last trading period.

    With a Sell rating, Citigroup initiated coverage on Principal Financial Group Inc (NASDAQ:PFG). The price target seems to have been set at $63.00 for Principal Finl Gr. For the first quarter, Principal Finl Gr had an EPS of $1.63, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $80.36 and a 52-week-low of $58.66. At the end of the last trading period, Principal Finl Gr closed at $70.53.

    With a Buy rating, Citigroup initiated coverage on MetLife Inc (NYSE:MET). The price target seems to have been set at $77.00 for MetLife. MetLife earned $2.08 in the first quarter, compared to $2.20 in the year-ago quarter. The current stock performance of MetLife shows a 52-week-high of $73.18 and a 52-week-low of $55.21. Moreover, at the end of the last trading period, the closing price was at $63.95.

    Citigroup initiated coverage on Lincoln National Corp (NYSE:LNC) with a Neutral rating. The price target for Lincoln National is set to $56.00. In the first quarter, Lincoln National showed an EPS of $1.66, compared to $1.82 from the year-ago quarter. The current stock performance of Lincoln National shows a 52-week-high of $77.57 and a 52-week-low of $50.55. Moreover, at the end of the last trading period, the closing price was at $54.03.

    With a Buy rating, HC Wainwright & Co. initiated coverage on Tanzanian Gold Corp (AMEX:TRX). The price target seems to have been set at $0.70 for Tanzanian Gold. The current stock performance of Tanzanian Gold shows a 52-week-high of $0.60 and a 52-week-low of $0.26. Moreover, at the end of the last trading period, the closing price was at $0.32.

    Citigroup initiated coverage on The Hartford Financial Services Group Inc (NYSE:HIG) with a Buy rating. The price target for Hartford Finl Servs Gr is set to $81.00. In the first quarter, Hartford Finl Servs Gr showed an EPS of $1.66, compared to $0.56 from the year-ago quarter. The current stock performance of Hartford Finl Servs Gr shows a 52-week-high of $78.17 and a 52-week-low of $59.86. Moreover, at the end of the last trading period, the closing price was at $68.63.

    Citigroup initiated coverage on Equitable Holdings Inc (NYSE:EQH) with a Buy rating. The price target for Equitable Holdings is set to $41.00. In the first quarter, Equitable Holdings showed an EPS of $1.53, compared to $1.35 from the year-ago quarter. The stock has a 52-week-high of $37.13 and a 52-week-low of $25.73. At the end of the last trading period, Equitable Holdings closed at $28.79.

    Citigroup initiated coverage on Chubb Ltd (NYSE:CB) with a Neutral rating. The price target for Chubb is set to $209.00. Chubb earned $3.82 in the first quarter, compared to $2.52 in the year-ago quarter. The stock has a 52-week-high of $218.99 and a 52-week-low of $155.78. At the end of the last trading period, Chubb closed at $207.31.

    Citigroup initiated coverage on Allstate Corp (NYSE:ALL) with a Buy rating. The price target for Allstate is set to $159.00. For the first quarter, Allstate had an EPS of $2.58, compared to year-ago quarter EPS of $6.11. At the moment, the stock has a 52-week-high of $144.46 and a 52-week-low of $106.11. Allstate closed at $125.66 at the end of the last trading period.

    Citigroup initiated coverage on Aflac Inc (NYSE:AFL) with a Neutral rating. The price target for Aflac is set to $60.00. For the first quarter, Aflac had an EPS of $1.42, compared to year-ago quarter EPS of $1.53. At the moment, the stock has a 52-week-high of $67.20 and a 52-week-low of $51.28. Aflac closed at $56.53 at the end of the last trading period.

    With a Sell rating, Citigroup initiated coverage on Progressive Corp (NYSE:PGR). The price target seems to have been set at $93.00 for Progressive. Progressive earned $1.11 in the first quarter, compared to $1.73 in the year-ago quarter. The current stock performance of Progressive shows a 52-week-high of $120.17 and a 52-week-low of $89.35. Moreover, at the end of the last trading period, the closing price was at $112.94.

    With a Buy rating, Rosenblatt initiated coverage on Imax Corp (NYSE:IMAX). The price target seems to have been set at $25.00 for Imax. Imax earned $0.14 in the first quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $23.57 and a 52-week-low of $13.60. At the end of the last trading period, Imax closed at $15.68.

    With a Buy rating, Rosenblatt initiated coverage on Harmonic Inc (NASDAQ:HLIT). The price target seems to have been set at $15.00 for Harmonic. In the first quarter, Harmonic showed an EPS of $0.08, compared to $0.04 from the year-ago quarter. The current stock performance of Harmonic shows a 52-week-high of $12.22 and a 52-week-low of $6.69. Moreover, at the end of the last trading period, the closing price was at $9.27.

    With a Buy rating, Rosenblatt initiated coverage on Dolby Laboratories Inc (NYSE:DLB). The price target seems to have been set at $90.00 for Dolby Laboratories. In the second quarter, Dolby Laboratories showed an EPS of $0.92, compared to $0.91 from the year-ago quarter. The current stock performance of Dolby Laboratories shows a 52-week-high of $104.25 and a 52-week-low of $69.18. Moreover, at the end of the last trading period, the closing price was at $75.34.

    Guggenheim initiated coverage on Syneos Health Inc (NASDAQ:SYNH) with a Buy rating. The price target for Syneos Health is set to $81.00. Syneos Health earned $1.01 in the first quarter, compared to $0.79 in the year-ago quarter. The current stock performance of Syneos Health shows a 52-week-high of $104.18 and a 52-week-low of $66.73. Moreover, at the end of the last trading period, the closing price was at $71.47.

    Guggenheim initiated coverage on Medpace Holdings Inc (NASDAQ:MEDP) with a Neutral rating. Medpace Hldgs earned $1.69 in the first quarter, compared to $1.14 in the year-ago quarter. The stock has a 52-week-high of $231.00 and a 52-week-low of $126.94. At the end of the last trading period, Medpace Hldgs closed at $133.72.

    Guggenheim initiated coverage on IQVIA Holdings Inc (NYSE:IQV) with a Buy rating. The price target for IQVIA Hldgs is set to $244.00. For the first quarter, IQVIA Hldgs had an EPS of $2.47, compared to year-ago quarter EPS of $2.18. The stock has a 52-week-high of $285.61 and a 52-week-low of $195.57. At the end of the last trading period, IQVIA Hldgs closed at $203.39.

    With a Buy rating, Guggenheim initiated coverage on Icon PLC (NASDAQ:ICLR). The price target seems to have been set at $285.00 for Icon. In the first quarter, Icon showed an EPS of $2.76, compared to $2.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $313.00 and a 52-week-low of $199.01. Icon closed at $217.58 at the end of the last trading period.

    For Charles River Laboratories International Inc (NYSE:CRL), Guggenheim initiated coverage, by setting the current rating at Neutral. For the first quarter, Charles River had an EPS of $2.75, compared to year-ago quarter EPS of $2.53. At the moment, the stock has a 52-week-high of $460.21 and a 52-week-low of $217.19. Charles River closed at $231.24 at the end of the last trading period.

    With a Market Perform rating, Bernstein initiated coverage on eBay Inc (NASDAQ:EBAY). The price target seems to have been set at $50.00 for eBay. In the first quarter, eBay showed an EPS of $1.05, compared to $1.09 from the year-ago quarter. The current stock performance of eBay shows a 52-week-high of $81.19 and a 52-week-low of $43.28. Moreover, at the end of the last trading period, the closing price was at $45.19.

    Bernstein initiated coverage on Wayfair Inc (NYSE:W) with an Underperform rating. The price target for Wayfair is set to $45.00. In the first quarter, Wayfair showed an EPS of $1.96, compared to $1.00 from the year-ago quarter. The stock has a 52-week-high of $339.56 and a 52-week-low of $46.66. At the end of the last trading period, Wayfair closed at $50.22.

    With an Underperform rating, Bernstein initiated coverage on Zillow Group Inc (NASDAQ:ZG). The price target seems to have been set at $34.00 for Zillow Gr. Zillow Gr earned $0.49 in the first quarter, compared to $0.44 in the year-ago quarter. At the moment, the stock has a 52-week-high of $124.90 and a 52-week-low of $33.26. Zillow Gr closed at $40.92 at the end of the last trading period.

    With an Outperform rating, Bernstein initiated coverage on DoorDash Inc (NYSE:DASH). The price target seems to have been set at $90.00 for DoorDash. In the first quarter, DoorDash showed an EPS of $0.48, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $257.25 and a 52-week-low of $57.60. At the end of the last trading period, DoorDash closed at $67.81.

    With an Outperform rating, Bernstein initiated coverage on Etsy Inc (NASDAQ:ETSY). The price target seems to have been set at $105.00 for Etsy. For the first quarter, Etsy had an EPS of $0.60, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $307.75 and a 52-week-low of $72.66. At the end of the last trading period, Etsy closed at $76.07.

    SVB Leerink initiated coverage on Horizon Therapeutics PLC (NASDAQ:HZNP) with a Market Perform rating. The price target for Horizon Therapeutics is set to $95.00. In the first quarter, Horizon Therapeutics showed an EPS of $1.34, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $120.53 and a 52-week-low of $82.51. At the end of the last trading period, Horizon Therapeutics closed at $87.38.

    See all analyst ratings initiations.

    Get the next $AFL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFL
    $ALL
    $CB
    $CRL

    CompanyDatePrice TargetRatingAnalyst
    Medpace Holdings Inc.
    $MEDP
    2/10/2026$564.00Neutral → Outperform
    Robert W. Baird
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    Roblox Corporation
    $RBLX
    2/6/2026$159.00 → $105.00Buy
    Needham
    Otis Worldwide Corporation
    $OTIS
    1/30/2026$98.00Overweight → Neutral
    Analyst
    Zillow Group Inc.
    $ZG
    1/29/2026$72.00Underweight → Equal Weight
    Barclays
    Eaton Corporation PLC
    $ETN
    1/16/2026$400.00Hold → Buy
    HSBC Securities
    Lattice Semiconductor Corporation
    $LSCC
    1/15/2026$105.00Outperform
    RBC Capital Mkts
    Zillow Group Inc.
    $ZG
    1/14/2026$85.00Outperform
    BNP Paribas Exane
    More analyst ratings

    $AFL
    $ALL
    $CB
    $CRL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer's Disease

    Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for Registrational Development Boca Raton, FL, Feb. 12, 2026 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB) ("INmune Bio" or the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that it received the official minutes from its End-of-Phase 2 (Type B) meeting with the U.S. Food and Drug Administration (FDA).  The minutes confirm regulatory alignment on the Company's proposed integrated Phase 2b/3 clinical development strategy for XPro1595 in early Alzheimer's Disease (AD). "The outcome of the End-of-Phase 2 interaction i

    2/12/26 7:00:00 AM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Equitable Holdings Announces Additional $1 Billion Share Repurchase Authorization and Declares Common and Preferred Stock Dividends

    Equitable Holdings, Inc. (NYSE:EQH), the leading financial services holding company of Equitable, AllianceBernstein and Equitable Advisors, announced today that its Board of Directors has approved an additional $1 billion share repurchase authorization. Under this authorization, the Company may, from time to time, purchase shares of its common stock through various means including open market transactions, privately negotiated transactions, forward, derivative, accelerated repurchase, or automatic share repurchase transactions, or tender offers. The authorization for the share repurchase program may be terminated, increased or decreased by the Board of Directors at any time. The Company

    2/11/26 4:15:00 PM ET
    $EQH
    Specialty Insurers
    Finance

    RESAAS Announces Snowflake Integration for Enterprise Real Estate Data

    Integration Between RESAAS and Snowflake Unlocks Enterprise-Grade Insights from Proprietary Real Estate Data VANCOUVER, BC, Feb. 11, 2026 /PRNewswire/ - RESAAS Services Inc. ("RESAAS" or "the Company") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, today announced an integration with Snowflake (NYSE:SNOW), the AI Data Cloud company, enabling RESAAS's top-tier enterprise clients to seamlessly synchronize proprietary real estate data captured through the RESAAS platform directly into their existing Snowflake environments. The i

    2/11/26 8:30:00 AM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Chappuis Jacques bought $100,970 worth of shares (1,000 units at $100.97) (SEC Form 4)

    4 - PRUDENTIAL FINANCIAL INC (0001137774) (Issuer)

    2/9/26 4:51:20 PM ET
    $PRU
    Life Insurance
    Finance

    Large owner Prudential Insurance Co Of America bought $34,985,590 worth of Class I common shares of beneficial interest (1,406,739 units at $24.87) (SEC Form 4)

    4 - PRUDENTIAL FINANCIAL INC (0001137774) (Reporting)

    1/27/26 4:30:32 PM ET
    $PRU
    Life Insurance
    Finance

    Director Krall David bought $499,044 worth of shares (47,528 units at $10.50), increasing direct ownership by 27% to 223,125 units (SEC Form 4)

    4 - HARMONIC INC. (0000851310) (Issuer)

    12/15/25 7:50:36 PM ET
    $HLIT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    SEC Filings

    View All

    SEC Form 10-K filed by The Travelers Companies Inc.

    10-K - TRAVELERS COMPANIES, INC. (0000086312) (Filer)

    2/12/26 6:51:29 AM ET
    $TRV
    Property-Casualty Insurers
    Finance

    Lincoln National Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LINCOLN NATIONAL CORP (0000059558) (Filer)

    2/12/26 6:05:47 AM ET
    $LNC
    Life Insurance
    Finance

    SEC Form 6-K filed by ICON plc

    6-K - ICON PLC (0001060955) (Filer)

    2/12/26 6:02:28 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AFL
    $ALL
    $CB
    $CRL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medpace upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Medpace from Neutral to Outperform and set a new price target of $564.00

    2/10/26 1:55:33 PM ET
    $MEDP
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Roblox upgraded by Roth Capital with a new price target

    Roth Capital upgraded Roblox from Neutral to Buy and set a new price target of $84.00

    2/9/26 6:58:32 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Needham reiterated coverage on Roblox with a new price target

    Needham reiterated coverage of Roblox with a rating of Buy and set a new price target of $105.00 from $159.00 previously

    2/6/26 8:28:08 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Off. & Corp. Sec. Reinstra Mark converted options into 118,110 shares and sold $2,493,475 worth of shares (34,320 units at $72.65), increasing direct ownership by 23% to 454,322 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:57:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Chief People & Systems Officer Chakravarthy Arvind converted options into 114,776 units of Class A Common Stock and sold $6,639,886 worth of Class A Common Stock (95,895 units at $69.24), increasing direct ownership by 33% to 240,570 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:56:36 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    President & CEO Baszucki David converted options into 893,068 shares and sold $19,782,756 worth of shares (272,269 units at $72.66), increasing direct ownership by 326% to 811,373 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:55:53 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lyra Therapeutics Inc.

    SC 13D/A - Lyra Therapeutics, Inc. (0001327273) (Subject)

    12/16/24 9:02:59 PM ET
    $LYRA
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

    SC 13G/A - Oncocyte Corp (0001642380) (Subject)

    12/9/24 5:30:06 PM ET
    $OCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Marqeta Inc.

    SC 13G/A - Marqeta, Inc. (0001522540) (Subject)

    11/27/24 8:47:26 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    Leadership Updates

    Live Leadership Updates

    View All

    Milan Kovac Joins DoorDash Board of Directors

    DoorDash, Inc. (NASDAQ:DASH) announced today that Milan Kovac, former Vice President of Optimus Robotics and Autopilot at Tesla, has been appointed to the company's Board of Directors, effective January 16, 2026. Tony Xu, co-founder and CEO of DoorDash, Inc., said, "Milan has spent his career building and scaling ambitious engineering programs at the intersection of AI, autonomy, and robotics. He brings a rare combination of technical depth and operational leadership. That experience will be invaluable as we continue to build products and infrastructure that help local businesses grow, give consumers access to more of their communities, and create new ways for people to earn. I'm excited

    1/20/26 4:05:00 PM ET
    $DASH
    EDP Services
    Technology

    Marqeta Announces Appointment of Patti Kangwankij as CFO

    Marqeta, Inc. (NASDAQ:MQ), the modern card issuing platform, today announced the appointment of Patti Kangwankij as the Company's Chief Financial Officer, effective February 9, 2026. Ms. Kangwankij will oversee all aspects of Marqeta's financial operations, supporting the Company's strategy to drive rapid growth and enhanced profitability. She will succeed Mike Milotich as CFO who, as previously announced, was appointed Marqeta's Chief Executive Officer in September 2025. Ms. Kangwankij is an experienced finance executive with over 20 years of experience across the technology, financial and global payments industries. She will join Marqeta from real estate technology company Roofstock, wh

    1/7/26 9:00:00 AM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    $AFL
    $ALL
    $CB
    $CRL
    Financials

    Live finance-specific insights

    View All

    Equitable Holdings Announces Additional $1 Billion Share Repurchase Authorization and Declares Common and Preferred Stock Dividends

    Equitable Holdings, Inc. (NYSE:EQH), the leading financial services holding company of Equitable, AllianceBernstein and Equitable Advisors, announced today that its Board of Directors has approved an additional $1 billion share repurchase authorization. Under this authorization, the Company may, from time to time, purchase shares of its common stock through various means including open market transactions, privately negotiated transactions, forward, derivative, accelerated repurchase, or automatic share repurchase transactions, or tender offers. The authorization for the share repurchase program may be terminated, increased or decreased by the Board of Directors at any time. The Company

    2/11/26 4:15:00 PM ET
    $EQH
    Specialty Insurers
    Finance

    Zillow Group Reports Fourth-Quarter and Full-Year 2025 Financial Results

    SEATTLE, Feb. 10, 2026 /PRNewswire/ -- Zillow Group, Inc. (NASDAQ:Z), which is transforming the way people buy, sell, rent and finance homes, today announced its consolidated financial results for the three months and year ended December 31, 2025. Complete financial results, and outlook for the first quarter of 2026, can be found in the shareholder letter on the Investor Relations section of Zillow Group's website at https://investors.zillowgroup.com/investors/financials/quarterly-results/default.aspx.  "We delivered strong results in the fourth quarter and throughout 2025, ac

    2/10/26 4:05:00 PM ET
    $Z
    $ZG
    Real Estate

    Lattice Semiconductor Reports Record Communications & Computing Revenue For Full Year 2025

    Guides 37% Year Over Year Revenue Growth for 1Q26 Lattice Semiconductor Corporation (NASDAQ:LSCC), the low power programmable leader, announced financial results today for the fiscal fourth quarter and full year ended January 3, 2026. Revenue for the full year 2025 was $523.3 million, with GAAP gross margin of 68.2% and GAAP net income of $0.02 per diluted share. On a non-GAAP basis, gross margin was 69.3%, with net income per diluted share of $1.05. GAAP net income and GAAP net income margin for the full year 2025 were $3.1 million and 0.6%, respectively, with adjusted EBITDA of $183.0 million and a 35.0% adjusted EBITDA margin for the full year 2025. Revenue for the fourth quarter o

    2/10/26 4:00:00 PM ET
    $LSCC
    Semiconductors
    Technology

    $AFL
    $ALL
    $CB
    $CRL
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care